PRMT5 and breast cancer: Among these, epigenetic modifiers that were previously implicated in breast cancer cell fitness, such as PRMT5 [51], HDAC3 [52], NPM1 [53, 54] were depleted in MDA-MB-231 cells serving as positive controls.